Bayer Valproic Acid Assay for ACS:180 and Advia Centaur Analyzers
510(k) K013959
Active
Valid until
No expiry
FDA recalls
None foundDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK013959 | Date29 Jan 2002 | StatusActive |
Recalls
No FDA recalls found in the data synced 6 Oct 2026.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- Full name
- Bayer Valproic Acid Assay for the ACS:180 and Advia Centaur Analyzers
- 510(k) Number
- FDA Product Code
- DKB
- Device Class
- Class II
- Regulation
- 21 CFR Part 862.3200
- Advisory Committee
- Clinical Toxicology
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 1 Oct 2026
The Bayer Valproic Acid Assay is a Drug Mixture and Calibrator designed for quantitative measurement of valproic acid in patient samples. It is intended for use with the Bayer ACS:180 and Advia Centaur immunoassay analyzers, enabling clinical toxicology assessments to monitor therapeutic drug levels or detect toxicity. The assay leverages immunoassay technology to provide accurate and reliable valproic acid concentration readings, supporting clinical decision-making in patient care.
This assay is supplied as a reagent kit for in vitro diagnostic use, requiring preparation and calibration on designated analyzers. It is intended for single-use per manufacturer specifications and does not require sterilization beyond standard laboratory handling. The device is classified under FDA regulation 862.3200 and holds a 510(k) clearance under the Traditional pathway, with a Substantially Equivalent determination by the Clinical Toxicology Advisory Committee. Compliance with FDA_510K (K013959) ensures adherence to regulatory standards for diagnostic accuracy and safety.
Other devices from Bayer Diagnostics Corp.
Questions
AI-generated answers, 1 Oct 2026
What is the Bayer Valproic Acid Assay designed for?
The Bayer Valproic Acid Assay is an in vitro diagnostic reagent kit designed specifically for quantitative measurement of valproic acid concentrations in patient samples. It is intended for use with the Bayer ACS:180 and Advia Centaur immunoassay analyzers to assist clinicians in monitoring therapeutic drug levels or detecting potential toxicity in clinical toxicology assessments.
How is the Bayer Valproic Acid Assay supplied and prepared?
The assay is supplied as a reagent kit for in vitro diagnostic use. It requires preparation and calibration directly on the designated ACS:180 or Advia Centaur analyzers before use. The kit includes all necessary components for performing the immunoassay, but setup and calibration must be completed according to the manufacturer’s instructions to ensure accurate results.
Is the Bayer Valproic Acid Assay single-use or reusable?
The Bayer Valproic Acid Assay is designed for single-use per manufacturer specifications. Each kit is intended for a limited number of tests as outlined in the accompanying documentation, and components should not be reused to maintain accuracy and prevent cross-contamination.
Does the Bayer Valproic Acid Assay require sterilization?
No, the assay does not require additional sterilization beyond standard laboratory handling procedures. As an in vitro diagnostic reagent kit, it is packaged and stored under controlled conditions to ensure sterility and reliability, but routine lab practices for cleanliness and contamination prevention should still be followed.
What regulatory pathway does the Bayer Valproic Acid Assay follow?
The assay holds an FDA 510(k) clearance under the Traditional pathway, with a Substantially Equivalent determination by the Clinical Toxicology Advisory Committee. This classification ensures compliance with FDA regulations for diagnostic accuracy and safety, specifically under device classification 862.3200 for calibrators and drug mixtures.